Dave Fornell, ITN Editor
Dave Fornell, ITN Editor

Dave Fornell is the editor of Diagnostic & Interventional Cardiology magazine and assistant editor for Imaging Technology News magazine.

Blog | Dave Fornell, ITN Editor | AAPM | August 14, 2018

The Hottest Topics in Medical Physics at AAPM 2018

Cherenkov radiation imaging during radiation therapy

Cherenkov radiation imaging during radiation therapy

I attended the American Association of Physicists in Medicine (AAPM) 2018 meeting in late July and came back with many takeaways.

 

Artificial Intelligence

Artificial intelligence (AI) was the biggest single topic discussed in sessions and on the show floor at AAPM 2018, reflecting the same trend ITN has seen at medical conferences over the past year. AI is being developed to help automate treatment planning software and cut the time it takes to develop plans from hours or days, down to minutes. Examples of AI auto-segmentation and contouring was shown in the RaySearch booth on the floor and demonstrated in dozens of sessions.

I spoke with Steve Jiang, Ph.D., director of the medical artificial intelligence and automation lab and vice-chair of the Department of Radiation Oncology, University of Texas Southwestern. He spoke in sessions at AAPM 2018 about how AI will change treatment planning, radiation oncology and medical imaging. Watch the VIDEO interview with him where he explains these areas in more detail here.

I also spoke to Kevin Moore, Ph.D., deputy director of medical physics, University of California San Diego, about his daily clinical use of an artificial intelligence treatment planning software he helped develop with a partner vendor. He said the accuracy is very good after being compared to manual planning over the course of three years. He said the past few years were a refinement period to teach the AI how to perform better by correcting any errors the system made so it knew how to plan better in similar cases in the future.

Radiological Society of North America (RSNA) President Vijay Rao, M.D., spoke at AAPM about the strong partnership between AAPM and RSNA. She is the David C. Levin professor and chair of radiology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia. I spoke to her after her session and she said AI has exploded across medicine and particularly in radiology. She said the trend in AI seen at AAPM is the same across 10 other imaging conferences she has attended as RSNA president over the past several months. She said AI will also by far be the hottest topic discussed at RSNA 2018 in late November.

 

Redefining the Future of Medical Physics in a Changing Healthcare Environment

This was the topic that several in AAPM leadership wanted to stress as the role of medical physicists is augmented in the coming years by automation and AI.

AAPM President Bruce Thomadsen, M.D., professor of medical physics at the University of Wisconsin, Madison, highlighted this theme in his presidential symposium, and it was echoed by several other speakers in sessions. He said the future may seem uncertain due to AI and automation, but it also presents opportunities for physicists to reinvent their roles in healthcare. You can watch a VIDEO interview with Thomadsen at AAPM here.

Thomadsen mentioned AAPM's Medical Physics 3.0 initiative, which is aimed at helping redefine how physicists can help not just in treatment planning and radiology imaging system quality assurance, but perhaps become more active in patient care and offer services to other departments.

I spoke with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Group and head of the Duke medical physics graduate program, who explained this new program in detail. He said physicists need to get out of the back rooms and interface more with other specialities across the hospital. You can watch a VIDEO interview with Samei at AAPM here

Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor or radiology and cardiology and chief physicist at Johns Hopkins, also shared his views on this same topic of the changing role of physicists in this VIDEO interview

 

Application of Radiomics in Both Medical Imaging and Radiation Therapy

Numerous sessions explained how use of big data analytics and software image analysis algorithms applied to medical imaging can enhance disease diagnosis. This includes finding small variations in images that may escape the naked eye that show similarities in various types of cancers. When tied with electronic medical records (EMR), data and oncology reports, this may allow for better disease classification, prognosis prediction, allow better recommendations for treatment and better disease staging.

One of these radiomics presenters was Martin Vallieres, Ph.D., post-doctoral fellow at McGill University, Montreal, Canada, presented on radiomics, and also sat down to discuss the topic with ITN

 

New Technology is Constantly Evolving

The sessions at AAPM were packed with new concepts on how to better treat or image patients. I included several of these new technologies in the VIDEO Editor's Choice of the Most Innovative New Technology from the show floor at AAPM 2018. 

One interesting session I sat in on at AAPM included how to use proton beams from proton radiation therapy systems as an onboard real-time image guidance system. I spoke with Matthew Freeman, Ph.D., scientist at Los Alamos National Laboratory, New Mexico, who is helping develop direct proton imaging on the treatment table without the need for other external or on-board imaging systems. Watch a VIDEO interview with him here. 

Another topic that has been discussed for several years, and again at AAPM 2018, was the use of Cherenkov radiation imaging during radiation therapy to help confirm plan and dose delivery in real time. There were several sessions where researchers from various institutions showed how this concept works as a science project. However, the most interesting presentation of how this might work in the real world was on the expo floor by a new vendor seeking to file for U.S. Food and Drug Administration (FDA) clearance of Cherenkov imaging system. Here is a VIDEO explaining two patient cases. 

It is interesting to note that on social media, ITN’s postings of these two patient case videos received the highest level of interest and reader engagement out of all the posts made during AAPM. While it is a science project in the eyes of many people, there was a lot of interest in the possibility of this technology being commercialized.

Find additional AAPM coverage here.

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 07, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Children and teenagers with COVID-19...
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand